PARRY, ROMANI, DECONCINI & SYMMS for BRAIDWOOD MANAGEMENT, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. Support of H. Con. Res. 342 and S. Con. Res. 88, Expressing the sense of Congress that the Food and Drug Admin.'s new policy restricting women's access to medications containing estriol does not serve the public interest (intro. in House & Senate).
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER New | Committee's Subcommittee on Patents, Copyrightsand Trademarks: 1987 to 1990 |
| DENNIS DECONCINI New | U.S. Senator, 1977 to 1995 |
| JAMES ROCK New | — |
| ROMANO ROMANI New | — |
| THADDEUS E STROM New | Gen Counsel/Staff Dir, Sen Cmte on the Judiciary - 1988-1991Chief Counsel/Staff Dir, Sen Cmte on the Judiciary-1991-1993Chief Counsel/Staff Dir, Sen Subcommittee on Antitrust,Business Rights and Competition - 1994 - 1997 |
| STEVE SYMMS New | — |
Pharmacy PHA
Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. Support of H. Con. Res. 342 and S. Con. Res. 88, Expressing the sense of Congress that the Food and Drug Admin.'s new policy restricting women's access to medications containing estriol does not serve the public interest (intro. in House & Senate).
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER New | Committee's Subcommittee on Patents, Copyrightsand Trademarks: 1987 to 1990 |
| DENNIS DECONCINI New | U.S. Senator, 1977 to 1995 |
| JAMES ROCK New | — |
| ROMANO ROMANI New | — |
| THADDEUS E STROM New | Gen Counsel/Staff Dir, Sen Cmte on the Judiciary - 1988-1991Chief Counsel/Staff Dir, Sen Cmte on the Judiciary-1991-1993Chief Counsel/Staff Dir, Sen Subcommittee on Antitrust,Business Rights and Competition - 1994 - 1997 |
| STEVE SYMMS New | — |
Medical/Disease Research/Clinical Labs MED
Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. Support of H. Con. Res. 342 and S. Con. Res. 88, Expressing the sense of Congress that the Food and Drug Admin.'s new policy restricting women's access to medications containing estriol does not serve the public interest (intro. in House & Senate).
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER New | Committee's Subcommittee on Patents, Copyrightsand Trademarks: 1987 to 1990 |
| DENNIS DECONCINI New | U.S. Senator, 1977 to 1995 |
| JAMES ROCK New | — |
| ROMANO ROMANI New | — |
| THADDEUS E STROM New | Gen Counsel/Staff Dir, Sen Cmte on the Judiciary - 1988-1991Chief Counsel/Staff Dir, Sen Cmte on the Judiciary-1991-1993Chief Counsel/Staff Dir, Sen Subcommittee on Antitrust,Business Rights and Competition - 1994 - 1997 |
| STEVE SYMMS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.